Form 4 · Filed Jun 3, 2026, 09:02 PM UTC
IOVA/IOVANCE BIOTHERAPEUTICS, INC.
Vogt Frederick G — Interim CEO & General Counsel
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | M | other | 41,668 | $0 | — | 571,206 |
| Jun 1, 2026 | F | other | 17,701 | $4 | $70,096 | 553,505 |
| Jun 1, 2026 | M | other | 41,668 | — | — | 125,007 |
Source: SEC EDGAR raw filing ↗ · Accession 0001104659-26-070155